These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 2873872

  • 1. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
    Seizinger BR, Liebisch DC, Kish SJ, Arendt RM, Hornykiewicz O, Herz A.
    Brain Res; 1986 Jul 23; 378(2):405-8. PubMed ID: 2873872
    [Abstract] [Full Text] [Related]

  • 2. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
    Dawbarn D, Zamir N, Waters CM, Hunt SP, Emson PC, Brownstein MJ.
    Brain Res; 1986 Apr 30; 372(1):155-8. PubMed ID: 2871898
    [Abstract] [Full Text] [Related]

  • 3. Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia.
    Zamir N, Skofitsch G, Bannon MJ, Helke CJ, Kopin IJ, Jacobowitz DM.
    Brain Res; 1984 Nov 26; 322(2):356-60. PubMed ID: 6150750
    [Abstract] [Full Text] [Related]

  • 4. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R, Gaudreau P, Martel JC, St-Pierre S, Zamir N.
    Brain Res; 1985 Apr 08; 331(2):358-62. PubMed ID: 2859094
    [Abstract] [Full Text] [Related]

  • 5. Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling.
    Iadarola MJ, Shin C, McNamara JO, Yang HY.
    Brain Res; 1986 Feb 12; 365(1):185-91. PubMed ID: 2868784
    [Abstract] [Full Text] [Related]

  • 6. Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.
    Iadarola MJ, Ofri D, Kleinman JE.
    Life Sci; 1991 Feb 12; 48(20):1919-30. PubMed ID: 1708847
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE, Landis DM, Zalneraitis EL.
    Brain Res; 1983 Dec 19; 289(1-2):11-26. PubMed ID: 6198034
    [Abstract] [Full Text] [Related]

  • 8. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR, Forno LS, Eng LF.
    J Neuropathol Exp Neurol; 1985 Jan 19; 44(1):47-59. PubMed ID: 2578185
    [Abstract] [Full Text] [Related]

  • 9. Distribution pattern of metorphamide compared with other opioid peptides from proenkephalin and prodynorphin in the bovine brain.
    Sonders M, Weber E.
    J Neurochem; 1987 Sep 19; 49(3):671-80. PubMed ID: 3612117
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical localization of dynorphin (1-8) in hypothalamic magnocellular neurons: evidence for absence of proenkephalin.
    Weber E, Roth KA, Evans CJ, Chang JK, Barchas JD.
    Life Sci; 1987 Sep 19; 31(16-17):1761-4. PubMed ID: 6130434
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Occurrence of methionine-enkephalin-Arg6-Gly7-Leu8 with methionine-enkephalin, leucine-enkephalin and methionine-enkephalin-Arg6-Phe7 in human gastric antrum.
    Sakamoto M, Nakao K, Yoshimasa T, Ikeda Y, Suda M, Takasu K, Shimbo S, Yanaihara N, Imura H.
    J Clin Endocrinol Metab; 1983 Jan 19; 56(1):202-4. PubMed ID: 6847871
    [Abstract] [Full Text] [Related]

  • 13. Proenkephalin and prodynorphin related neuropeptides in the cochlea.
    Hoffman DW, Zamir N, Rubio JA, Altschuler RA, Fex J.
    Hear Res; 1985 Jan 19; 17(1):47-50. PubMed ID: 2860094
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
    Nylander I, Terenius L.
    Brain Res; 1986 Aug 13; 380(1):34-41. PubMed ID: 2428423
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP.
    Neuroscience; 1988 May 13; 25(2):419-38. PubMed ID: 2456487
    [Abstract] [Full Text] [Related]

  • 18. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA, Day R, Akil H.
    Brain Res; 1990 Jun 04; 518(1-2):244-56. PubMed ID: 1975215
    [Abstract] [Full Text] [Related]

  • 19. Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat.
    Chesselet MF, Graybiel AM.
    Life Sci; 1983 Jun 04; 33 Suppl 1():37-40. PubMed ID: 6141495
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical localization of Met-enkephalin, Met-enkephalin-Arg6-Gly7-Leu8, Met-enkephalin-Arg6-Phe7 and Leu-enkephalin in human adrenal medulla and pheochromocytomas.
    Osamura RY, Watanabe K, Yoshimasa T, Nakao K, Imura H.
    Peptides; 1984 Jun 04; 5(5):993-1000. PubMed ID: 6390360
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.